Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.

Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O'Dell J, Winthrop KL, Beukelman T, Bridges SL Jr, Chatham WW, Paulus HE, Suarez-Almazor M, Bombardier C, Dougados M, Khanna D, King CM, Leong AL, Matteson EL, Schousboe JT, Moynihan E, Kolba KS, Jain A, Volkmann ER, Agrawal H, Bae S, Mudano AS, Patkar NM, Saag KG.

Arthritis Care Res (Hoboken). 2012 May;64(5):625-39. doi: 10.1002/acr.21641. Review. No abstract available.

2.

Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor.

Todd DJ, Knowlton N, Amato M, Frank MB, Schur PH, Izmailova ES, Roubenoff R, Shadick NA, Weinblatt ME, Centola M, Lee DM.

Arthritis Rheum. 2011 Apr;63(4):894-903. doi: 10.1002/art.30213.

3.

A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation.

Rhodes B, Merriman ME, Harrison A, Nissen MJ, Smith M, Stamp L, Steer S, Merriman TR, Vyse TJ.

PLoS Med. 2010 Sep 21;7(9):e1000341. doi: 10.1371/journal.pmed.1000341.

4.

Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study.

Iannaccone CK, Lee YC, Cui J, Frits ML, Glass RJ, Plenge RM, Solomon DH, Weinblatt ME, Shadick NA.

Rheumatology (Oxford). 2011 Jan;50(1):40-6. doi: 10.1093/rheumatology/keq263. Epub 2010 Sep 16.

PMID:
20847201
5.

Evaluation of selected rheumatoid arthritis activity scores for office-based assessment.

Sullivan MB, Iannaccone C, Cui J, Lu B, Batra K, Weinblatt M, Shadick NA.

J Rheumatol. 2010 Dec;37(12):2466-8. doi: 10.3899/jrheum.091349. Epub 2010 Sep 1.

PMID:
20810513
6.

Correlation of a multi-cytokine panel with clinical disease activity in patients with rheumatoid arthritis.

Milman N, Karsh J, Booth RA.

Clin Biochem. 2010 Nov;43(16-17):1309-14. doi: 10.1016/j.clinbiochem.2010.07.012. Epub 2010 Jul 23.

PMID:
20655893
7.

Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic?

de Rooy DP, van der Linden MP, Knevel R, Huizinga TW, van der Helm-van Mil AH.

Rheumatology (Oxford). 2011 Jan;50(1):93-100. doi: 10.1093/rheumatology/keq230. Epub 2010 Jul 16.

PMID:
20639266
8.

Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis.

Kurosaka D, Hirai K, Nishioka M, Miyamoto Y, Yoshida K, Noda K, Ukichi T, Yanagimachi M, Furuya K, Takahashi E, Kingetsu I, Fukuda K, Yamada A.

J Rheumatol. 2010 Jun;37(6):1121-8. doi: 10.3899/jrheum.090941. Epub 2010 May 1.

9.

Evidence for treating rheumatoid arthritis to target: results of a systematic literature search.

Schoels M, Knevel R, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas DT, Burmester G, Combe B, Cutolo M, Dougados M, Emery P, van der Heijde D, Huizinga TW, Kalden J, Keystone EC, Kvien TK, Martin-Mola E, Montecucco C, de Wit M, Smolen JS.

Ann Rheum Dis. 2010 Apr;69(4):638-43. doi: 10.1136/ard.2009.123976. Review. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.

10.

Treating rheumatoid arthritis to target: recommendations of an international task force.

Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D; T2T Expert Committee.

Ann Rheum Dis. 2010 Apr;69(4):631-7. doi: 10.1136/ard.2009.123919. Epub 2010 Mar 9. Erratum in: Ann Rheum Dis. @011 Jul;70(7):1349. van der Heijde, Desirée [corrected to van der Heijde, Désirée]. Ann Rheum Dis. 2011 Aug;70(8):1519.

11.
12.

Standardization of joint examination technique leads to a significant decrease in variability among different examiners.

Grunke M, Antoni CE, Kavanaugh A, Hildebrand V, Dechant C, Schett G, Manger B, Ronneberger M.

J Rheumatol. 2010 Apr;37(4):860-4. doi: 10.3899/jrheum.090195. Epub 2010 Feb 15.

PMID:
20156953
13.

Circulating TNFRI and TNFRII levels correlated with the disease activity score (DAS28) in rheumatoid arthritis.

Valle Y, Ledezma-Lozano IY, Torres-Carrillo N, Padilla-Gutiérrez JR, Navarro-Hernández RE, Vázquez-Del Mercado M, Palafox-Sánchez CA, Armendáriz-Borunda J, Muñoz-Valle JF.

Scand J Rheumatol. 2009;38(5):332-5. doi: 10.1080/03009740902865456.

PMID:
19579138
16.

Test-retest reliability of disease activity core set measures and indices in rheumatoid arthritis.

Uhlig T, Kvien TK, Pincus T.

Ann Rheum Dis. 2009 Jun;68(6):972-5. doi: 10.1136/ard.2008.097345. Epub 2008 Oct 28.

PMID:
18957489
19.

Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial.

van der Heijde D, Landewé R, van Vollenhoven R, Fatenejad S, Klareskog L.

Ann Rheum Dis. 2008 Sep;67(9):1267-70. doi: 10.1136/ard.2007.081331. Epub 2008 Jan 18.

20.

Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate.

Parker A, Izmailova ES, Narang J, Badola S, Le T, Roubenoff R, Ginsburg GS, Maier A, Coblyn JS, Shadick NA, Weinblatt ME.

J Rheumatol. 2007 Sep;34(9):1817-22. Epub 2007 Aug 1.

PMID:
17696278

Supplemental Content

Support Center